Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac insights ...

Austin, Texas, United States, January 5th, 2026, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...

Automated diagnosis of chronic obstructive pulmonary disease using deep learning applied to electrocardiogramsJournal: eBioMedicine ...

Clearance for First-Ever Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment Pivotal Milestone Unlocks ...

Would you pay for a $600 scale that informs you of your risk of hypertension and cardiac efficiency? Withings is betting big that you will.

The Withings Body Scan 2 detects over 60 biomarkers as well as your weight, including hypertension, metabolism, and body fat .

AP31969 is a novel, first-in-class, oral SK ion channel inhibitor intended for rhythm control of atrial fibrillation and has recently completed Phase 1 in ...

Everus just posted record revenue, expanding margins, and higher guidance, so why would a disciplined fund trim now?

Withings presents the Body Scan 2 body composition scale at CES 2026. The device is said to record over 60 health values and ...

This presentation outlines the key technology trends defining CES 2026, contextualised by the current global and US economic ...

Every personal problem is also a social problem. This means that most of our problems, no matter how personal they may seem, are connected with the type of society we live in.